Early to moderate type 2 diabetes For patients with type 2 diabetes who have not achieved adequate control with metformin alone, GLP-1 receptor agonists are increasingly the second-line choice
Like we moved away from calling something a day cream or a night cream because there's really no reason why you couldn't use one at any time of the day
Under high-glucose-induced neurotoxicity, procyanidin B2 has been shown to improve oxidative stress, block neuronal death, promote neural regeneration, and increase the cell survival of DRG neurons (Zhang et al
The dataset included information on 41 million lives, with prescription and mortality data spanning from 2015 to January 1, 2025
GLP-1 medications have helped many individuals achieve results that previously felt out of reach, but they work best when integrated into a comprehensive strategy focused on nutrition, exercise, metabolic health, and long-term sustainability